Broadfin Capital, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2019$13,217,000
+20.8%
721,073
-27.0%
1.77%
-12.5%
Q3 2019$10,944,000
-31.1%
987,760
-36.7%
2.02%
-41.4%
Q2 2019$15,882,000
+41.9%
1,561,617
-18.2%
3.46%
+49.5%
Q1 2019$11,193,000
-23.0%
1,909,995
-6.7%
2.31%
+20.9%
Q4 2018$14,541,000
-0.1%
2,048,0250.0%1.91%
-10.8%
Q3 2018$14,561,000
+41.6%
2,048,0250.0%2.14%
+32.4%
Q2 2018$10,281,000
-58.2%
2,048,025
-8.4%
1.62%
-57.8%
Q1 2018$24,619,000
+9.3%
2,236,025
-8.2%
3.84%
+4.2%
Q4 2017$22,533,000
-19.1%
2,436,025
-21.4%
3.68%
-10.6%
Q3 2017$27,839,000
+27.7%
3,100,0860.0%4.12%
+55.5%
Q2 2017$21,794,000
-19.6%
3,100,0860.0%2.65%
-19.3%
Q1 2017$27,095,000
+8.4%
3,100,0860.0%3.28%
+18.3%
Q4 2016$24,987,000
+15.4%
3,100,086
+26.5%
2.77%
+42.9%
Q3 2016$21,659,000
+32.2%
2,450,086
+18.9%
1.94%
+21.9%
Q2 2016$16,378,000
+33.2%
2,060,0860.0%1.59%
+34.0%
Q1 2016$12,299,000
-33.7%
2,060,0860.0%1.19%
+4.2%
Q4 2015$18,541,000
-25.2%
2,060,0860.0%1.14%
-17.3%
Q3 2015$24,783,000
+35.7%
2,060,086
+45.7%
1.38%
+40.6%
Q2 2015$18,263,000
+42.4%
1,413,5330.0%0.98%
-1.8%
Q1 2015$12,821,000
+58.6%
1,413,533
-50.0%
1.00%
+183.8%
Q4 2014$8,086,000
+133.0%
2,827,066
+141.2%
0.35%
-3.3%
Q3 2014$3,470,000
-67.8%
1,172,195
-12.8%
0.36%
-31.3%
Q2 2014$10,768,000
+133.5%
1,344,390
+113.4%
0.53%
+18.6%
Q1 2014$4,612,000630,0000.45%
Other shareholders
RECRO PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 850,129$2,423,0000.65%
Newtyn Management, LLC 700,000$1,995,0000.46%
Portolan Capital Management 1,293,376$3,686,0000.34%
Rubric Capital Management LP 1,076,587$3,068,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 99,046$282,0000.04%
Alyeska Investment Group, L.P. 736,821$2,100,0000.03%
STEPHENS INC /AR/ 510,569$1,455,0000.03%
Clear Harbor Asset Management, LLC 46,682$133,0000.02%
WYNNEFIELD CAPITAL INC 13,000$37,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 451,301$1,286,0000.01%
View complete list of RECRO PHARMA INC shareholders